0000899243-19-002316.txt : 20190201
0000899243-19-002316.hdr.sgml : 20190201
20190201163045
ACCESSION NUMBER: 0000899243-19-002316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190131
FILED AS OF DATE: 20190201
DATE AS OF CHANGE: 20190201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Orlandi Cesare
CENTRAL INDEX KEY: 0001610664
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36569
FILM NUMBER: 19560193
MAIL ADDRESS:
STREET 1: C/O LANTHEUS HOLDINGS, INC.
STREET 2: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: NY
ZIP: 01862
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantheus Holdings, Inc.
CENTRAL INDEX KEY: 0001521036
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 352318913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
BUSINESS PHONE: 978 671-8001
MAIL ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
FORMER COMPANY:
FORMER CONFORMED NAME: Lantheus MI Holdings, Inc.
DATE OF NAME CHANGE: 20110517
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-31
0
0001521036
Lantheus Holdings, Inc.
LNTH
0001610664
Orlandi Cesare
C/O LANTHEUS HOLDINGS, INC.
331 TREBLE COVE ROAD
NORTH BILLERICA
MA
01862
0
1
0
0
Chief Medical Officer
Common Stock
2019-01-31
4
S
0
3060
16.561
D
77746
D
Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.31 to $16.82, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
/s/ Michael P. Duffy, attorney-in-fact
2019-02-01